Stereoselective Syntheses of Octadecanoids, 9(S)‑HODE, and 9(S),10(S),13(S)‑TriHOME Authors: Myeongsu Shin, Youngjoo Byun Published: 2026 ABSTRACT Octadecanoids and their metabolites are known to be biologically active lipid mediators. 9­(S)-HODE and 9­(S),10­(S),13­(S)-TriHOME, the main metabolites of linoleic acid produced by 15-lipoxygenase, exhibit enantioselective potency and function as endogenous ligands in biological systems. However, the structural modification of 9­(S)-HODE and 9­(S),10­(S),13­(S)-TriHOME in pharmaceutical applications remains largely underexplored. Herein, we report the stereoselective syntheses of 9­(S)-HODE and 9­(S),10­(S),13­(S)-TriHOME to enable access to bioactive octadecanoid analogues. Introduction Octadecanoids, oxygenated metabolites of linoleic acid (LA), have been reported as a diverse class of bioactive lipid mediators involved in the inhibition of cancer metastasis, anti-inflammatory signaling pathways, pain perception, epidermal barrier formation, and antioxidant defense. , Several metabolites of linoleic acid have been reported to act as potent lipid mediators, including 9­(S)-hydroxyoctadecadienoic acid (9­(S)-HODE, 11a), 9-oxo-octadecadienoic acid (9-oxo-ODE, 12), and 9,10,13-trihydroxyoctadecenoic acid (9,10,13-TriHOME, 26a and 26b) (Figure ). 15-Lipoxygenase-2 (15-LOX-2) catalyzes the stereospecific oxygenation of LA to form 9­(S)-hydroperoxyoctadecadienoic acid (9S-HpODE), which can be reduced by glutathione peroxidase (GPx) to 9­(S)-HODE with a conjugated diene system. 9­(S)-HODE is subsequently metabolized to 9-oxo-ODE by hydroxy fatty acid dehydrogenase. Both 9­(S)-HODE and 9-oxo-ODE function as endogenous ligands of the peroxisome proliferator-activated receptor-γ (PPARγ). , In addition to PPARγ activation, 9­(S)-HODE acts as a ligand for the G2A (GPR132) receptor and promotes pro-inflammatory signaling pathways in human keratinocytes, contributing to skin photoinduced skin aging. , It has also been reported to modulate nociceptive signaling via TRPV1 activation, suggesting a role as a lipid mediator of pain. Consistent with its PPARγ activity, 9-HODE induces the expression of fatty acid-binding protein 4 (FABP4) in macrophages and monocytes in a PPARγ-dependent manner. In the 15-LOX-1 metabolic pathway, 15-LOX-1 oxygenates a stereospecific position on LA, generating 13­(S)-hydroperoxylinoleic acid (13­(S)-HpODE), which is further metabolized by GPx to 13­(S)-hydroxyoctadecadienoic acid (13­(S)-HODE) with a conjugated diene. 13­(S)-HODE has been identified as an endogenous inhibitor of mTOR, directly binding to the kinase domain and suppressing its activity. Subsequently, 13­(S)-HODE is oxidized to 13-oxo-ODE by hydroxy fatty acid dehydrogenase. 13-Oxo-ODE mediates biological effects through PPARγ-dependent signaling pathways. Alternatively, hydroperoxide isomerization of 13­(S)-HpODE leads to the formation of 11­(E)-13­(S)-OH-EpOME, which can be converted into racemic 9,10,13­(S)-TriHOME by enzyme-mediated or spontaneous hydrolysis. It is known that TriHOMEs are predominantly found in the (S) configuration at position C-13, which is consistent with lipoxygenase-mediated oxidation of linoleic acid. They have been detected in biological samples such as bronchoalveolar lavage fluid (BALF) from COPD patients, highlighting their physiological relevance. In addition, 9,10,13-TriHOME has gained increasing importance due to its involvement in human diseases. Esterified TriHOMEs also contribute to the formation of the mammalian epidermal barrier, while free TriHOME modulates nociception via TRPV1 activation. Recently, octadecanoids are increasingly recognized as bioactive lipid mediators involved in various physiological and pathological processes. Targeted metabolomic analyses of lipid oxidation identified 9­(S),10­(S),13­(S)-TriHOME as an oxidized lipid within oxylipin networks that converge in inflammation-related lipid pathways. Therefore, the synthesis of enantiomerically pure 9­(S)-HODE and 9­(S),10­(S),13­(S)-TriHOME, as well as their enantiomers, offers the potential to be used as tool compounds for elucidating pharmacological functions. Linoleic acid (LA)-derived octadecanoids by lipoxygenases (LOX). Biosynthetic pathways of linoleic acid (LA)-derived octadecanoids mediated by 15-lipoxygenases (15-LOX), adapted from the literature. − , The synthesis of 13­(S)-HODE and 13-oxo-ODE was reported previously by us (black dashed box), , while compounds 11a, 12, and 26a are described in this work (pink dashed box). Recent advances in synthetic chemistry have focused on functionalization strategies that enable the rapid diversification of complex molecules and facilitate applications in drug discovery and chemical biology. − These advances have provided access to structurally diverse bioactive lipid mediators. Several 9,10,13-triHOME isomers and analogues have been studied to understand the relationship between their chemical structure and biological activities. In addition, the syntheses of 13­(S)-HODE and its analogues have been previously reported by us. , However, the structural modifications of 9­(S)-HODE and 9­(S),10­(S),13­(S)-TriHOME for pharmaceutical applications have not yet been comprehensively investigated. Several total syntheses of 9­(S)-HODE and 9­(R),10­(R),13­(R)-TriHOME have been reported to date, ,− and two representative studies are summarized in Figure A. The total synthesis of 9­(S)-HODE was reported in 2007 by Naidu et al. The key step involved the cross-coupling reaction between 1-heptyne and a vinyl iodide derived from an enantiomerically enriched alkyne, followed by partial hydrogenation under Lindlar conditions, elimination of the protecting group with 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ), and final oxidation to furnish 9­(S)-HODE in 16 steps. For the synthesis of 9­(S)-HODE, our method is shorter than the previously described synthesis (12 steps compared with 16 steps). While the enantiomeric purity was determined in the earlier study using the diol intermediate (99% ee), we determined the ee value of the final product, 9­(S)-HODE (99% ee). Furthermore, a chemical enantioselective synthesis of 9­(R)-HODE has not yet been reported. In the case of TriHOME, Davis et al. reported the synthesis of 9­(R),10­(R),13­(R)-TriHOME methyl ester using a chiral pool strategy starting from commercially available (D)-tartaric acid. In this approach, the (9R, 10R)-aldehyde intermediate was condensed with a ketophosphonate to afford the corresponding 9­(R),10­(R)-enone, followed by an asymmetric reduction to furnish the major isomer 9­(R),10­(R),13­(R)-TriHOME in 12 synthetic steps. However, this approach required diastereomer separation (9:1 d.r.; determined at an intermediate stage) and relied on Mosher ester analysis, without quantitative determination of ee for the final product. Our method, while not shorter in terms of the total number of steps, offers significantly improved stereoselectivity (greater than 99.5% ee compared to the previously reported d.r. of 9:1). Importantly, our stereochemical results are confirmed by chiral HPLC (see the Supporting Information), thereby enabling access to stereochemically defined isomers. Furthermore, an enantioselective total synthesis of 9­(S),10­(S),13­(S)-TriHOME has not been described previously. More importantly, our synthesis strategy enables the efficient production of a variety of fatty acids. The late-stage synthesis approach allows for the bulk synthesis of common intermediates, which can then be coupled with diverse fragments using modular methods, such as the Sonogashira reaction. This accelerates the expansion of chemical libraries. Furthermore, performing (Z)- or (E)-selective reduction and asymmetric catalysis in a late-stage synthesis minimizes the risk of racemization while maximizing high stereochemical purity. We describe the synthesis of 9­(S)-HODE and 9­(S),10­(S),13­(S)-TriHOME and their enantiomers 9­(R)-HODE and 9­(R),10­(R),13­(R)-TriHOME. (A) Previous syntheses of 9­(S)-HODE and 9­(R),10­(R),13­(R)-TriHOME methyl ester. (B) Our synthetic work of 9­(S)-HODE, 9­(R)-HODE, 9­(S),10­(S),13­(S)-TriHOME, and 9­(R),10­(R),13­(R)-TriHOME. a ee determined by chiral HPLC analysis of the intermediate diol, b ee determined by chiral HPLC analysis of the final product, cd.r. determined at an intermediate stage; stereochemistry assigned by Mosher ester analysis, d ee determined by chiral HPLC analysis of the corresponding ester derivative. Results and Discussion The retrosynthesis of 9­(S)-HODE is shown in Scheme . 9­(S)-HODE (11a) can be traced back to intermediate 9a via hydrolysis and a (Z)-selective reduction. Intermediate 9a is derived from vinyl iodide 8a through Sonogashira cross-coupling with hept-1-yne, representing a key C–C bond disconnection. Vinyl iodide 8a was selected as a key intermediate because it contains the stereocenter and allows convergent bond formation. Intermediate 8a was successfully synthesized on a gram scale from the commercially available starting material, azelaic acid. This late-stage functionalization approach can be significantly expanded, enabling the synthesis of both natural and non-natural fatty acids through the precise linkage of alkynes of varying chain lengths with diverse vinyl iodides. The resulting internal alkyne structures can be converted into unsaturated fatty acids with cis- or trans-alkenes by controlled partial hydrogenation at specific sites. Retrosynthesis of the Core Structure for (9S)-HODE (11a) The synthesis of 9­(S)-HODE is shown in Scheme . The synthesis of compound 1 started with the cyclization of azelaic acid with acetic anhydride in quantitative yield, followed by the conversion of the resulting anhydride to Weinreb amide 2 using N,O-dimethylhydroxylamine in 48% yield. Subsequent addition of TIPS-acetylene to Weinreb amide 2 afforded the corresponding alkynyl ketone 3 in 59% yield. Esterification of the resulting carboxylic acid then furnished ketone 4 in 91% yield. Efficient conversion was achieved when the carboxylic acid functionality was retained in compound 2, while the corresponding ester substrate led to a lower conversion under the same conditions (Supporting Information Table S1). Asymmetric reduction of ketone 4 using Noyori’s catalyst − gave the desired enantiomer of alcohol (S)-5a in 96% yield (98% ee; determined by chiral HPLC of the corresponding derivative 28a; see the Supporting Information). TBAF-mediated desilylation of alkyne 5a, followed by silyl protection of the hydroxyl group of alkyne 6a, afforded the corresponding TES ether 7a in 86% yield over 2 steps. The conversion of terminal acetylene 7a into the corresponding (E)-vinyl iodide was achieved in two steps consisting of regioselective palladium-catalyzed hydrostannylation and subsequent iododestannylation to afford (E)-vinyl iodide 8a in 60% yield in the presence of Pd­(PPh3)4. The Sonogashira coupling of iodide 8a with hept-1-yne in the presence of CuI, Pd­(PPh3)4, and Et3N and the subsequent silyl deprotection afforded enyne 9a in 69% yield over two steps. The (Z)-selective reduction of diene-yne intermediate 9a afforded compound 10a using a Zn­(Cu/Ag) catalyst. The Zn­(Cu/Ag)-mediated reduction proceeds with high chemoselectivity, enabling late-stage formation of the (Z)-alkene without over-reduction. Finally, 9­(S)-HODE (11a) was synthesized by ester hydrolysis of 10a with aqueous LiOH in 81% yield (99% ee, determined by chiral HPLC). Oxidation of 11a using Dess–Martin periodinane afforded the corresponding carbonyl compound 12 in 89% yield. The enantiomeric counterpart 9­(R)-HODE (11b) was accessed from intermediate 4 via asymmetric transfer hydrogenation using RuCl­[(R,R)-TsDPEN]­(mesitylene), affording 11b in 8 steps (21.7% overall yield, 99% ee). The yields of compounds 2 and 8a are moderate, which could be due to purification losses. Further optimization of the purification protocol could improve efficiency. Synthesis of 9­(S)-HODE (11a), 9­(R)-HODE (11b), and 9-Oxo-ODE (12) The retrosynthetic analysis of 9­(S),10­(S),13­(S)-TriHOME is shown in Scheme . The structure of 9­(S),10­(S),13­(S)-TriHOME (26a) is accessible from intermediate 23a via an (E)-selective reduction of the alkyne. Intermediate 23a can be generated by Sharpless asymmetric dihydroxylation of enyne (S)-22a, furnishing the vicinal diol with high enantioselectivity. This late-stage reaction enables highly selective formation of the C9 and C10 stereocenters through reagent control, independent of the existing chirality at C13. Enyne intermediate (S)-22a can be obtained from chiral intermediate 16a and key intermediate 20 via Sonogashira coupling, representing a key C–C bond formation enabling convergent assembly of various carbon skeletons. Fragment 16a and vinyl iodide 20 can be prepared on a gram scale from commercially available starting materials. Retrosynthesis of the Core Structure for 9­(S),10­(S),13­(S)-TriHOME (26a) The synthesis of key intermediate 20 is shown in Scheme . (E)-Vinyl iodide 20 was prepared in a four-step sequence starting from commercial 8-bromooctanoic acid. Alkynylation of 8-bromooctanoic acid afforded the corresponding acetylene 17 in 93% yield. Esterification of the acid and subsequent TIPS deprotection gave alkyne 18 in 95% yield over two steps. DIBAL-H reduction of the resulting alkyne 18 furnished the corresponding aldehyde. Due to the incompatibility of the carbonyl group with the subsequent reducing conditions (e.g., DIBAL-H, LiHBEt3, and Red-Al), the aldehyde was protected as the corresponding cyclic acetal 19, which was obtained in 63% yield over two steps. Acetal 19 was then subjected to hydrozirconation with in situ-generated Schwartz reagent, followed by iodination to provide the key intermediate iodide 20 in 59% yield. The combination of Cp2ZrCl and LiHBEt3 proved optimal, affording higher yields with significantly reduced reaction time compared to the other conditions (Supporting Information Table S2). Synthesis of Key Intermediate 20 The synthesis of 9­(S),10­(S),13­(S)-TriHOME (26a) is shown in Scheme . Following a previously published procedure, the enantioselective synthesis of intermediate 16a was achieved in 63% yield over four steps. Activation of known hexanoic acid afforded the corresponding Weinreb amide 13 in 86% yield, and the subsequent reaction with TIPS-acetylene furnished ketone 14 in 91% yield. Asymmetric reduction of ketone 14 using Noyori’s catalyst afforded the desired enantiomer of 15a in 90% yield. Subsequent desilylation of alcohol 15a furnished chiral alkyne 16a in 90% yield. The Sonogashira coupling of alkyne 16a and iodide 20 with CuI, Pd­(PPh3)4, and Et3N afforded enyne 21a in 43% yield. Benzoylation of enyne 21a afforded protected intermediate (S)-22a in 89% yield, and subsequent Sharpless asymmetric dihydroxylation using (DHQ)2PHAL and K2OsO4·2H2O furnished vicinal diol 23a in 80% yield with high enantiomeric excess (ee ≥ 99.5%). Deprotection of compound 23a with LiOH in THF/H2O removed the benzoyl group, and subsequent reduction of the crude residue with Red-Al (15 equiv) afforded the desired triol 24a in 60% yield over two steps. Red-Al was chosen for this conversion due to its compatibility with acetal protecting groups and based on literature examples. Under these conditions, the reaction proceeded efficiently and quickly (see Supporting Information Table S3). The total synthesis of TriHOME was completed in four further steps. Silylation of triol 24a proceeded in 87% yield, followed by selective removal of cyclic acetal 25a in the presence of TMSOTf and 2,6-lutidine while retaining the TES protecting groups to afford the crude aldehyde. Oxidation of the aldehyde using NaClO2 and NaH2PO4, followed by deprotection of the TES groups with TBAF, afforded 9­(S),10­(S),13­(S)-TriHOME (26a) in 51% yield over two steps. Although the yield in this step was not high, further optimization of the isolation process could lead to higher yields. The (R)-enantiomer was prepared from precursor (R)-22b via Sharpless asymmetric dihydroxylation using (DHQD)2PHAL, providing 9­(R),10­(R),13­(R)-TriHOME (26b) in 6 steps (19.3% overall yield, ee ≥ 99.5%; determined by chiral HPLC of the corresponding ester derivative 29b; see the Supporting Information). The synthetic and analytical data of 9­(S)- and 9­(R)-HODE, as well as 9­(S),10­(S),13­(S)- and 9­(R),10­(R),13­(R)-TriHOME, were consistent with previously reported data. ,,, 9­(S)- and 9­(R)-HODE were obtained in 5.6% and 5.5% overall yields, respectively, over 12 steps (99% ee in each case). 9­(S),10­(S),13­(S)- and 9­(R),10­(R),13­(R)-TriHOME were prepared in 2.7% and 2.9% overall yields, respectively, over 15 steps (ee ≥ 99.5% in each case). Enantioselective Synthesis of 9­(S),10­(S),13­(S)-TriHOME (26a) and 9­(R),10­(R),13­(R)-TriHOME (26b) Conclusion In summary, the stereoselective syntheses of 9­(S)-HODE (11a) and 9­(S),10­(S),13­(S)-TriHOME (26a), and their enantiomers 9­(R)-HODE (11b) and 9­(R),10­(R),13­(R)-TriHOME (26b), were successfully achieved in 12 and 15 synthetic steps, respectively, with high enantioselectivity (ee > 99%). The reagent-controlled approach in the late stage of synthesis is suitable for the synthesis of fatty acid analogues. By integrating various alkyne fragments with diverse vinyl iodides via Sonogashira coupling, followed by (Z)- or (E)-selective hydrogenation and chiral induction in the late stage of synthesis, this synthetic methodology enables the efficient generation of fatty acid isomers from a common intermediate and is useful for structure–activity relationship studies. This modular approach enables structural diversification and supports future medicinal chemistry studies of octadecanoids, which have the potential to modulate intracellular target proteins such as fatty acid-binding proteins and mTOR kinases. Experimental Section All of the chemicals and solvents used in the reaction were purchased from Sigma-Aldrich, TCI, or Thermo Fisher Scientific and were used without further purification. All reactions were carried out in oven-dried glassware under an inert atmosphere, and the reaction temperature was controlled by an oil bath. Reactions were monitored by TLC on 0.25 mm Merck precoated silica gel plates (60 F254). Reaction progress was monitored by TLC analysis using a UV lamp and/or KMnO4 staining or p-anisaldehyde staining solution for detection purposes. Column chromatography was performed on silica gel (230–400 mesh, Merck, Darmstadt, Germany). 1H and 13C NMR spectra were recorded at room temperature (298 K) in CDCl3 (7.26 ppm/77.16 ppm), CD3OD (3.31 ppm/49.00 ppm), or CD3CN/D2O (2.53 and 4.79 ppm/1.32 and 118.26 ppm) on a Bruker Ultrashield 600 MHz Plus spectrometer and referenced to an internal solvent. NMR solvents, including CDCl3, CD3OD, CD3CN, and D2O, were used as received from the Eurisotop company. Chemical shifts (δ) are reported in parts per million (ppm). Coupling constants (J) are given in Hertz. Splitting patterns are indicated as s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, double of doublet; dt, double of triplet; br, broad for 1H NMR data. High-resolution mass spectra (HRMS) were recorded on an Agilent 6530 Accurate mass Q-TOF LC/MS spectrometer. The purity of all final compounds was measured by an analytical C18 column (250 × 4.6 mm, Nacalai Cosmosil Cholester packed column) using water/ACN containing 0.1% formic acid as the mobile phase. The enantiomeric ratio was determined by chiral HPLC (250 mm × 4.6 mm, 5 μm, Daicel Chiralpak IG) using hexane/MTBE containing 0.05% glacial acetic acid as the mobile phase. All compounds were detected at 220 nm using a UV detector. The purities of the tested compounds were >95%. Optical rotation was measured at λ = 589 nm, corresponding to the sodium D line, at the indicated temperature using a Krüss P8000 polarimeter. Oxecane-2,10-dione (1) To a solution of azelaic acid (10.0 g, 53.1 mmol) in acetic anhydride (100 mL), the reaction mixture was heated at reflux for 12 h. The reaction mixture was concentrated by coevaporation with xylene. The residue was recrystallized from Hex/Ether (1:1) to afford crude product 1 as a beige solid (9.13 g, quantitative yield). 1H NMR (600 MHz, CDCl3) δ 2.43 (t, J = 7.4 Hz, 4H), 1.64 (q, J = 6.9 Hz, 4H), 1.38–1.31 (m, 6H); 13C NMR (151 MHz, CDCl3) δ 169.6, 35.3, 28.8, 28.7, 24.2; HRMS (ESI) m/z: [M + Na]+ calculated for C9H14O3Na+, 193.0835; found, 193.0842. 9-(Methoxy­(methyl)­amino)-9-oxononanoic Acid (2) To a solution of anhydride 1 (1.0 g, 5.87 mmol) in DCM (20 mL) were added N,O-dimethylhydroxylamine·HCl (630 mg, 6.46 mmol, 1.1 equiv) and pyridine (1.04 mL, 12.9 mmol, 2.2 equiv) at room temperature. The reaction mixture was stirred at room temperature for 12 h and concentrated under reduced pressure. The residue was diluted with DCM and water. The organic layer was washed with saturated aqueous NH4Cl and brine, dried over MgSO4, filtered, and concentrated. The residue was purified by column chromatography on silica gel using DCM/MeOH (98:2) with 0.1% AcOH to give product 2 as a colorless oil (650 mg, 48%). R f = 0.2 (DCM/MeOH (98:2), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 3.67 (s, 3H), 3.17 (s, 3H), 2.40 (t, J = 7.0 Hz, 2H), 2.33 (t, J = 7.5 Hz, 2H), 1.65–1.58 (m, 4H), 1.36–1.30 (m, 6H); 13C NMR (151 MHz, CDCl3) δ 179.4, 61.3, 34.1, 32.3, 31.9, 29.3, 29.1, 29.0, 24.8, 24.7; HRMS (ESI) m/z: [M + H]+ calculated for C11H22NO4 +, 232.1544; found, 232.1526. 9-Oxo-11-(triisopropylsilyl)­undec-10-ynoic Acid (3) TIPS-acetylene (2.66 mL, 11.9 mmol, 2.5 equiv) was dissolved in anhydrous THF (30 mL) and cooled to −78 °C before the addition of n-BuLi (2.5 M in hexane, 4.75 mL, 11.9 mmol, 2.5 equiv) under an argon atmosphere. The reaction mixture was stirred at −78 °C for 1 h, after which a solution of the above Weinreb amide 2 in THF (3 mL) was added. The reaction was slowly warmed to room temperature and stirred overnight. The reaction was quenched with saturated aqueous NH4Cl, and the pH was adjusted to 2–3 by the addition of 1.0 M HCl. The aqueous layer was extracted with EtOAc (2 × 50 mL). The combined organic layers were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/Ether (8:2) with 0.5% AcOH to afford pure product 3 as a colorless oil (983 mg, 59%). R f = 0.2 (Hex/Ether (8:2) with 0.5% AcOH, KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 2.55 (t, J = 7.4 Hz, 2H), 2.33 (t, J = 7.5 Hz, 2H), 1.68 (q, J = 7.2 Hz, 2H), 1.61 (q, J = 7.2 Hz, 2H), 1.36–1.30 (m, 6H), 1.15–1.06 (m, 21H); 13C NMR (151 MHz, CDCl3) δ 188.1, 180.2, 104.1, 95.7, 45.7, 34.1, 29.1, 29.0, 28.9, 24.7, 24.3, 18.6, 11.1; HRMS (ESI) m/z: [M – H]− calculated for C20H35O3Si–, 351.2361; found, 351.2380. Ethyl 9-Oxo-11-(triisopropylsilyl)­undec-10-ynoate (4) To a solution of acid 3 (875 mg, 2.5 mmol) in EtOH (20 mL) was added p-toluenesulfonic acid monohydrate (47.5 mg, 0.25 mmol, 0.1 equiv) at room temperature. The reaction mixture was stirred at 70 °C for 12 h and then concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (95:5) to give product 4 as a colorless oil (870 mg, 91%). R f = 0.2 (Hex/EtOAc (95:5), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 4.12 (q, J = 7.1 Hz, 1H), 2.55 (t, J = 7.4 Hz, 1H), 2.27 (t, J = 7.4 Hz, 1H), 1.69 (q, J = 7.2 Hz, 2H), 1.61 (q, J = 7.2 Hz, 2H), 1.31 (t, J = 6.6 Hz, 6H), 1.25 (t, J = 7.1 Hz, 3H), 1.14–1.06 (m, 21H); 13C NMR (151 MHz, CDCl3) δ 188.1, 173.9, 104.3, 95.6, 60.3, 45.7, 34.5, 29.1, 29.0, 28.9, 25.0, 24.3, 18.6, 14.4, 11.1; HRMS (ESI) m/z: [M + H]+ calculated for C22H41O3Si+, 381.2820; found, 381.2875. Ethyl (S)-9-Hydroxy-11-(triisopropylsilyl)­undec-10-ynoate (5a) To a solution of RuCl­[(S,S)-TsDPEN]­(mesitylene) (50.0 mg, 0.08 mmol, 0.03 equiv) in DCM (5 mL) was added KOH (30.5 mg, 0.54 mmol, 0.21 equiv), and the reaction mixture was stirred at room temperature for 45 min. The mixture was washed with H2O, and the DCM solution was transferred to another flask with DCM. The solution was dried over CaH2, and the supernatant was concentrated to afford a purple solid. The resulting solid was diluted with i-PrOH (4 mL), and a solution of ketone 4 (1.0 g, 2.62 mmol) in i-PrOH (4 mL) was added. After stirring at room temperature for 3 h, the reaction mixture was concentrated under reduced pressure to afford a residue, which was purified by chromatography on silica gel Hex/EtOAc (95:5) to afford alcohol 5a as a colorless oil (965 mg, 96%, 98% ee; determined by chiral HPLC of the corresponding derivative 28a; see the Supporting Information). The enantiomeric ratio was determined after TIPS deprotection and alcohol protection using Chiralpak IG; 10:90 hexane/MTBE containing 0.05% glacial acetic acid, 1.0 mL/min, 280 nm, t R = 7.01 min [99%, (S)-isomer], 9.66 min [1%, (R)-isomer]. R f = 0.2 (Hex/EtOAc (97:3), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 4.37 (q, J = 6.3 Hz, 1H), 4.12 (q, J = 7.1 Hz, 2H), 2.27 (t, J = 7.6 Hz, 2H), 1.82–1.78 (m, 1H), 1.74–1.65 (m, 2H), 1.64–1.58 (m, 2H), 1.50–1.42 (m, 2H), 1.36–1.29 (m, 6H), 1.25 (t, J = 7.1 Hz, 3H), 1.08 – 1.04 (m, 21H); 13C NMR (151 MHz, CDCl3) δ 174.0, 109.0, 85.5, 63.1, 60.3, 38.0, 34.5, 29.3, 29.2, 29.1, 25.2, 25.1, 18.7, 14.4, 11.3; HRMS (ESI) m/z: [M + Na]+ calculated for C22H42O3SiNa+, 405.2795; found, 405.2768. Ethyl (R)-9-Hydroxy-11-(triisopropylsilyl)­undec-10-ynoate (5b) Colorless oil (910 mg, 91%, 98% ee; determined by chiral HPLC of the corresponding derivative 28b; see the Supporting Information). R f = 0.2 (Hex/EtOAc (97:3), KMnO4 stain). The enantiomeric ratio was determined after TIPS deprotection and alcohol protection using Chiralpak IG; 10:90 hexane/MTBE containing 0.05% glacial acetic acid, 1.0 mL/min, 280 nm, tR = 7.27 min [1%, (S)-isomer], 10.38 min [99%, (R)-isomer]. R f = 0.2 (Hex/EtOAc (97:3), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 4.37 (q, J = 6.2 Hz, 1H), 4.11 (q, J = 7.1 Hz, 2H), 2.27 (t, J = 7.6 Hz, 2H), 1.83 (d, J = 5.4 Hz, 1H), 1.74–1.65 (m, 2H), 1.64–1.58 (m, 2H), 1.50–1.43 (m, 2H), 1.35–1.28 (m, 6H), 1.24 (t, J = 7.1 Hz, 3H), 1.08–1.04 (m, 21H); 13C NMR (151 MHz, CDCl3) δ 174.0, 109.1, 85.5, 63.1, 60.3, 38.0, 34.5, 29.3, 29.2, 29.1, 25.2, 25.1, 18.7, 14.4, 11.3; HRMS (ESI) m/z: [M + Na]+ calculated for C22H42O3SiNa+, 405.2795; found, 405.2761. Ethyl (S)-9-Hydroxyundec-10-ynoate (6a) To a solution of alcohol 5a (965 mg, 2.52 mmol) in THF (10 mL) was added TBAF (1.0 M in THF, 2.77 mL, 2.77 mmol, 1.1 equiv) at room temperature. After stirring for 1 h, the reaction was quenched with saturated aqueous NH4Cl, and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried over MgSO4, filtered, and concentrated under reduced pressure. Resulting ester 6a was used without further purification. R f = 0.25 (Hex/EtOAc (9:1), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 4.34–4.38 (m, 1H), 4.12 (q, J = 7.1 Hz, 2H), 2.45 (d, J = 2.1 Hz, 1H), 2.28 (t, J = 7.5 Hz, 2H), 1.87 (d, J = 5.2 Hz, 1H), 1.74–1.66 (m, 2H), 1.64–1.58 (m, 2H), 1.48–1.42 (m, 2H), 1.33 (d, J = 12.6 Hz, 6H), 1.25 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 174.0, 85.1, 73.0, 62.4, 60.3, 37.7, 34.5, 29.2, 29.1, 29.1, 25.1, 25.0, 14.4; HRMS (ESI) m/z: [M + Na]+ calculated for C13H22O3Na+, 249.1461; found, 249.1446. Ethyl (R)-9-Hydroxyundec-10-ynoate (6b) R f = 0.25 (Hex/EtOAc (9:1), KMnO4 stain) 1H NMR (600 MHz, CDCl3) δ 4.36 (td, J = 6.6, 2.1 Hz, 1H), 4.11 (q, J = 7.1 Hz, 2H), 2.45 (d, J = 2.1 Hz, 1H), 2.28 (t, J = 7.6 Hz, 2H), 1.95 (brs, 1H), 1.75–1.65 (m, 2H), 1.64–1.58 (m, 2H), 1.48–1.41 (m, 2H), 1.34–1.30 (m, 6H), 1.24 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 174.0, 85.2, 72.9, 62.4, 60.3, 37.7, 34.5, 29.2, 29.1, 29.1, 25.0, 25.0, 14.4; HRMS (ESI) m/z: [M + Na]+ calculated for C13H22O3Na+, 249.1461; found, 249.1473. Ethyl (S)-9-((Triethylsilyl)­oxy)­undec-10-ynoate (7a) To a solution of the above alcohol 6a in DCM (10 mL) were added imidazole (257 mg, 3.78 mmol, 1.5 equiv), DMAP (15.3 mg, 0.13 mmol, 0.05 equiv), and chlorotriethylsilane (634 μL, 3.78 mmol, 1.5 equiv) at room temperature. The reaction mixture was stirred at room temperature for 30 min and then diluted with DCM and saturated aqueous NaHCO3. The aqueous layer was extracted with DCM (2 × 50 mL). The combined extracts were washed with brine (2 × 50 mL), dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (97:3) to afford product 7a as a colorless oil (740 mg, 86%). R f = 0.2 (Hex/EtOAc (97:3), KMnO4 stain) 1H NMR (600 MHz, CDCl3) δ 4.33 (td, J = 6.5, 1.8 Hz, 1H), 4.12 (q, J = 7.2 Hz, 2H), 2.37 (d, J = 1.8 Hz, 1H), 2.28 (t, J = 7.6 Hz, 2H), 1.68–1.64 (m, 2H), 1.63–1.57 (m, 2H), 1.45–1.38 (m, 2H), 1.33–1.28 (m, 6H), 1.25 (t, J = 7.2 Hz, 3H), 0.97 (t, J = 8.0 Hz, 9H), 0.70–0.59 (m, 6H); 13C NMR (151 MHz, CDCl3) δ 174.0, 85.8, 72.0, 62.6, 60.3, 38.7, 34.5, 29.3, 29.2, 29.2, 25.2, 25.1, 14.4, 6.9, 4.9; HRMS (ESI) m/z: [M + H]+ calculated for C19H36O3Si+, 341.2507; found, 341.2529. Ethyl (R)-9-((Triethylsilyl)­oxy)­undec-10-ynoate (7b) Colorless oil (687 mg, 85%), R f = 0.2 (Hex/EtOAc (97:3), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 4.33 (td, J = 6.5, 1.8 Hz, 1H), 4.12 (q, J = 7.2 Hz, 2H), 2.37 (d, J = 1.8 Hz, 1H), 2.28 (t, J = 7.6 Hz, 3H), 1.68–1.63 (m, 2H), 1.63–1.58 (m, 2H), 1.45–1.38 (m, 2H), 1.33–1.28 (m, 6H), 1.25 (t, J = 7.2 Hz, 3H), 0.97 (t, J = 8.0 Hz, 9H), 0.70–0.59 (m, 6H); 13C NMR (151 MHz, CDCl3) δ 174.0, 85.8, 72.0, 62.6, 60.3, 38.7, 34.5, 29.3, 29.2, 29.2, 25.2, 25.1, 14.4, 6.9, 4.9; HRMS (ESI) m/z: [M + H]+ calculated for C19H36O3Si+, 341.2507; found, 341.2500. Ethyl (S,E)-11-Iodo-9-((triethylsilyl)­oxy)­undec-10-enoate (8a) To a solution of alkyne 7a (700 mg, 2.06 mmol) in THF (4 mL) were added Pd­(PPh3)4 (19.0 mg, 16.4 μmol, 0.8 mol %) and n-Bu3SnH (665 μL, 2.47 mmol, 1.2 equiv) at room temperature. The reaction mixture was stirred for 1 h, after which iodine (627 mg, 2.47 mmol, 1.2 equiv) was added at 4 °C, and the mixture was stirred for an additional 20 min. The reaction mixture was diluted with EtOAc (60 mL) and saturated aqueous KF (40 mL). The organic layer was washed with saturated aqueous Na2S2O3 and brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (98:2) to afford pure product 8a as a colorless liquid (580 mg, 60%). R f = 0.2 (Hex/EtOAc (98:2), KMnO4 stain) 1H NMR (600 MHz, CDCl3) δ 6.50 (dd, J = 14.4, 6.2 Hz, 1H), 6.20 (dd, J = 14.4, 0.8 Hz, 1H), 4.11 (q, J = 7.1 Hz, 2H), 4.05 (q, J = 6.2 Hz, 1H), 2.27 (t, J = 7.6 Hz, 2H), 1.63–1.57 (m, 2H), 1.49–1.41 (m, 2H), 1.32–1.26 (m, 6H), 1.25 (t, J = 7.1 Hz, 3H), 0.93 (t, J = 8.0 Hz, 9H), 0.57 (q, J = 8.0 Hz, 6H); 13C NMR (151 MHz, CDCl3) δ 174.0, 149.4, 75.9, 75.3, 60.3, 37.7, 34.5, 29.5, 29.3, 29.2, 25.1, 25.0, 14.4, 6.9, 5.0. Ethyl (R,E)-11-Iodo-9-((triethylsilyl)­oxy)­undec-10-enoate (8b) Colorless liquid (576 mg, 74%) R f = 0.2 (Hex/EtOAc (98:2), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 6.51 (dd, J = 14.4, 6.2 Hz, 1H), 6.20 (dd, J = 14.4, 1.0 Hz, 1H), 4.12 (q, J = 7.1 Hz, 2H), 4.05 (qd, J = 6.2, 1.0 Hz, 1H), 2.28 (t, J = 7.6 Hz, 2H), 1.64–1.57 (m, 2H), 1.50–1.40 (m, 2H), 1.32–1.26 (m, 6H), 1.25 (t, J = 7.1 Hz, 3H), 0.94 (t, J = 8.0 Hz, 9H), 0.57 (q, J = 8.0, 6H); 13C NMR (151 MHz, CDCl3) δ 174.0, 149.4, 75.9, 75.3, 60.3, 37.7, 34.5, 29.5, 29.3, 29.2, 25.1, 25.0, 14.4, 6.9, 5.0. Ethyl (S,E)-9-((Triethylsilyl)­oxy)­octadec-10-en-12-ynoate To a solution of hept-1-yne (95.1 μL, 0.72 mmol, 1.1 equiv) in Et3N (2 mL) were added Pd­(PPh3)4 (38.1 mg, 0.033 mmol, 0.05 equiv) and CuI (37.6 mg, 0.20 mmol, 0.3 equiv). The reaction mixture was stirred at room temperature for 5 min, after which a solution of vinyl iodide 8a (310 mg, 0.66 mmol) in Et3N (2 mL) was added. The reaction mixture was stirred at room temperature for 30 min and then diluted with EtOAc (30 mL) and saturated aqueous NH4Cl (20 mL). The aqueous layer was extracted with EtOAc, and the combined organic layers were washed with water and brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The resulting crude product was used in the next step without further purification. Ethyl (S,E)-9-Hydroxyoctadec-10-en-12-ynoate (9a) TBAF (1.0 M in THF, 660 μL, 1.0 equiv) was added to a solution of the above crude ester in THF (2.0 mL) at room temperature. The reaction mixture was stirred for 30 min and then diluted with EtOAc (15 mL) and saturated aqueous NH4Cl (10 mL). The organic layer was washed with water and brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (9:1) to afford pure product 9a as a brown oil (160.9 mg, 69%). R f = 0.2 (Hex/EtOAc (9:1), KMnO4 stain); 1H NMR (600 MHz, CDCl3) δ 6.03 (dd, J = 15.9, 6.5 Hz, 1H), 5.67 (ddd, J = 15.9, 3.2, 1.9 Hz, 1H), 4.14 – 4.09 (m, 3H), 2.32–2.25 (m, 4H), 1.61 (q, J = 7.2 Hz, 2H), 1.55–1.47 (m, 4H), 1.44–1.26 (m, 12H), 1.24 (d, J = 7.1 Hz, 3H), 0.90 (t, J = 7.2 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 174.0, 144.3, 110.7, 91.5, 78.5, 72.6, 60.3, 37.1, 34.5, 31.2, 29.4, 29.3, 29.2, 28.5, 25.3, 25.0, 22.3, 19.5, 14.4, 14.1; HRMS (ESI) m/z: [M + Na]+ calculated for C20H34O3Na+, 345.2400; found, 345.2366. Ethyl (R,E)-9-Hydroxyoctadec-10-en-12-ynoate (9b) Brown oil (170 mg, 80%). R f = 0.2 (Hex/EtOAc (9:1), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 6.03 (dd, J = 15.8, 6.5 Hz, 1H), 5.67 (ddd, J = 15.8, 3.3, 2.0 Hz, 1H), 4.14–4.08 (m, 3H), 2.30–2.25 (m, 4H), 1.63–1.57 (m, 2H), 1.55–1.47 (m, 4H), 1.40–1.28 (m, 12H), 1.25 (t, J = 7.1 Hz, 3H), 0.90 (t, J = 7.2 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 174.0, 144.3, 110.7, 91.5, 78.5, 72.6, 60.3, 37.1, 34.5, 31.2, 29.4, 29.3, 29.2, 28.5, 25.3, 25.0, 22.3, 19.5, 14.4, 14.1; HRMS (ESI) m/z: [M + Na]+ calculated for C20H34O3Na+, 345.2400; found, 345.2371. Ethyl (S,10E,12Z)-9-Hydroxyoctadeca-10,12-dienoate (10a) A mixture of zinc powder (4.8 g, 73.4 mmol, 200 equiv) and Cu­(OAc)2 (337 mg, 1.86 mmol, 5.0 equiv) in H2O (20 mL) was degassed by bubbling argon through the suspension for 20 min. AgNO3 (379 mg, 2.23 mmol, 6.0 equiv) was added, and the reaction mixture was stirred for 45 min. The resulting suspension was filtered using a glass filter. The remaining solid was washed sequentially with H2O, MeOH, acetone, and EtOAc. The solid residue was diluted with H2O (3 mL), and a solution of 9a in MeOH (3 mL) was added. The reaction mixture was stirred at 45 °C for 12 h and then filtered through a pad of Celite, washing with EtOAc. The filtrate was extracted with EtOAc (3 × 50 mL), and the combined organic layers were washed with brine, dried over MgSO4, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (9:1) to afford the product 10a as a colorless oil (93.3 mg, 78%). R f = 0.25 (Hex/EtOAc (9:1), KMnO4 stain); 1H NMR (600 MHz, CDCl3) δ 6.48 (dd, J = 15.1, 11.0 Hz, 1H), 5.96 (t, J = 11.0 Hz, 1H), 5.65 (dd, J = 15.1, 6.9 Hz, 1H), 5.47–5.41 (m, 1H), 4.14 (q, J = 6.3 Hz, 1H), 4.11 (t, J = 7.2 Hz, 2H), 2.27 (t, J = 7.5 Hz, 2H), 2.17 (q, J = 7.3 Hz, 2H), 1.64–1.57 (m, 2H), 1.56–1.47 (m, 2H), 1.38 (q, J = 7.2 Hz, 2H), 1.33–1.28 (m, 12H), 1.24 (t, J = 7.2 Hz, 3H), 0.88 (t, J = 6.9 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 174.0, 135.9, 133.2, 127.8, 126.0, 73.0, 60.3, 37.4, 34.5, 31.6, 29.5, 29.4, 29.3, 29.2, 27.9, 25.5, 25.1, 22.7, 14.4, 14.2. Ethyl (R,10E,12Z)-9-Hydroxyoctadeca-10,12-dienoate (10b) Colorless oil (78 mg, 80%). R f = 0.25 (Hex/EtOAc (9:1), KMnO4 stain) 1H NMR (600 MHz, CDCl3) δ 6.48 (dd, J = 15.0, 11.0 Hz, 1H), 5.96 (t, J = 11.0 Hz, 1H), 5.65 (dd, J = 15.0, 6.8 Hz, 1H), 5.44 (q, J = 7.9 Hz, 1H), 4.15 (q, J = 6.6 Hz, 1H), 4.11 (q, J = 7.2 Hz 2H), 2.28 (t, J = 7.5 Hz, 2H), 2.17 (q, J = 7.5 Hz, 2H), 1.63–1.58 (m, 3H), 1.57–1.48 (m, 2H), 1.37 (q, J = 6.6 Hz, 3H), 1.30 (s, 11H), 1.25 (t, J = 7.2 Hz, 3H), 0.88 (t, J = 6.5 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 174.0, 135.9, 133.2, 127.8, 126.0, 73.0, 60.3, 37.4, 34.5, 31.6, 29.5, 29.4, 29.3, 29.2, 27.9, 25.5, 25.1, 22.7, 14.4, 14.2. (S,10E,12Z)-9-Hydroxyoctadeca-10,12-dienoic Acid (11a) Compound 10a (85 mg, 0.26 mmol) was dissolved in a mixture of MeOH (1.0 mL), THF (1.0 mL), and water (0.5 mL), and LiOH (19 mg, 0.79 mmol, 3.0 equiv) was added at room temperature. The reaction mixture was stirred at 50 °C for 3 h. The reaction mixture was quenched by the addition of saturated aqueous NH4Cl and diluted with EtOAc. The aqueous layer was extracted with EtOAc (2 × 50 mL). The combined organic layers were washed with brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/Ether (8:2) containing 0.5% glacial acetic acid to afford crude product 11a as a white solid (63 mg, 81%, 99% ee; see the Supporting Information). The enantiomeric ratio was determined by Chiralpak IG; 10:90 hexane/MTBE containing 0.05% glacial acetic acid, 1.0 mL/min, 240 nm, t R = 10.21 min [99.5%, (S)-isomer], 6.56 min [0.5%, (R)-isomer]. R f = 0.25 (Hex/Ether (8:2) with 0.5% AcOH, KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 6.48 (dd, J = 15.1, 11.1 Hz, 1H), 5.96 (t, J = 11.1 Hz, 1H), 5.65 (dd, J = 15.1, 6.9 Hz, 1H), 5.45 (q, J = 7.8 Hz, 1H), 4.15 (q, J = 6.6 Hz, 1H), 2.34 (t, J = 7.5 Hz, 2H), 2.19–2.15 (m, 2H), 1.65–1.60 (m, 2H), 1.59–1.54 (m, 2H), 1.64–1.48 (m, 2H), 1.41–1.36 (m, 2H), 1.35–1.28 (m, 12H), 0.89 (t, J = 6.9 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 179.5, 135.8, 133.3, 127.8, 126.1, 73.1, 37.4, 34.1, 31.6, 29.5, 29.4, 29.3, 29.1, 27.9, 25.5, 24.8, 22.7, 14.2; HRMS (ESI) m/z: [M – H]− calculated for C18H31O3 –, 295.2278; found, 295.2282; [α] D 21 + 20.0 (c 0.5, MeOH), Lit. c [α] D 30 + 18 (c 0.03, MeOH). (R,10E,12Z)-9-Hydroxyoctadeca-10,12-dienoic Acid (11b) White solid (40 mg, 59%, 99% ee; see the Supporting Information). The enantiomeric ratio was determined by Chiralpak IG; 10:90 hexane/MTBE containing 0.05% glacial acetic acid, 1.0 mL/min, 240 nm, t R = 10.33 min [0.5%, (S)-isomer], 6.56 min [99.5%, (R)-isomer]. R f = 0.25 (Hex/Ether (8:2) with 0.5% AcOH, KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 6.48 (dd, J = 15.1, 11.0 Hz, 1H), 5.97 (t, J = 11.0 Hz, 1H), 5.65 (dd, J = 15.1, 6.9 Hz, 1H), 5.45 (q, J = 7.8 Hz, 1H), 4.15 (q, J = 6.6 Hz, 1H), 2.34 (t, J = 7.5 Hz, 2H), 2.19–2.14 (m, 2H), 1.65–1.60 (m, 2H), 1.59–1.48 (m, 2H), 1.42–1.35 (m, 2H), 1.35–1.27 (m, 12H), 0.89 (t, J = 6.9 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 179.6, 135.8, 133.3, 127.8, 126.1, 73.1, 37.4, 34.1, 31.6, 29.4, 29.4, 29.3, 29.1, 27.9, 25.5, 24.8, 22.7, 14.2; HRMS (ESI) m/z: [M – H]− calculated for C18H31O3 –, 295.2278; found, 295.2286; [α] D 21 −19.4 (c 0.5, MeOH). (10E,12Z)-9-Oxooctadeca-10,12-dienoic Acid (12) To a solution of acid 11a (20 mg, 0.068 mmol) in DCM (4 mL) was added Dess–Martin periodinane (15 wt % in DCM, 270 μL, 0.12 mmol, 1.7 equiv) at room temperature. The mixture was stirred at room temperature for 10 min and filtered through a pad of Celite. The filtrate was concentrated under reduced pressure, and the residue was purified by column chromatography on silica gel using Hex/Ether (8:2) containing 0.5% glacial acetic acid to afford crude product 12 as a white solid (17.8 mg, 89%). R f = 0.2 (Hex/Ether (8:2) with 0.5% AcOH, KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 5.66 (qd, J = 15.6, 4.1 Hz, 2H), 4.84 (t, J = 4.8 Hz, 1H), 4.14–4.09 (m, 2H), 3.99–3.93 (m, 2H), 3.87–3.81 (m, 2H), 3.57–3.53 (m, 1H), 1.66–1.62 (m, 2H), 1.52–1.48 (m, 2H), 1.43–1.38 (m, 2H), 1.32–1.24 (m, 14H), 0.98–0.93 (m, 27H), 0.87 (t, J = 7.0 Hz, 3H), 0.62–0.55 (m, 18H); 13C NMR (151 MHz, CDCl3) δ 134.00, 128.6, 104.9, 75.9, 75.0, 73.4, 65.0, 38.7, 34.1, 32.1, 31.4, 29.9, 29.7, 29.69, 26.3, 25.2, 24.3, 22.8, 14.2, 7.1, 7.1, 7.0, 5.3, 5.1, 5.1; HRMS (ESI) m/z: [M – H]− calculated for C18H29O3 –, 293.2122; found, 293.2128. N-Methoxy-N-methylhexanamide (13) Hexanoic acid (10.0 g, 86.1 mmol, 1.0 equiv) was dissolved in DCM (200 mL) at 4 °C followed by the addition of N,O-dimethylhydroxylamine hydrochloride (10.06 g, 103 mmol, 1.2 equiv), 1-ethyl-3-(3-(dimethylamino)­propyl)­carbodiimide hydrochloride (EDC·HCl) (19.8 g, 103 mmol, 1.2 equiv), DMAP (1.26 g, 8.61 mmol, 0.10 equiv), and triethylamine (28.8 mL, 103 mmol, 1.2 equiv). The reaction was stirred at room temperature for 3 h, and then the mixture was diluted with DCM and water. The layers were separated, and the organic layer was washed with 1.0 M HCl, saturated aqueous NaHCO3, and brine, dried over MgSO4, filtered, and concentrated under reduced pressure to afford crude Weinreb amide 13 (11.8 g, 86% crude yield), which was used in the next step without further purification. R f = 0.2 (Hex/EtOAc (9:1), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 3.67 (s, 3H), 3.17 (s, 3H), 2.40 (t, J = 7.4 Hz, 2H), 1.65–1.60 (m, 2H), 1.36–1.28 (m, 4H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 174.5, 61.3, 32.3, 32.0, 31.8, 24.5, 22.6, 14.1. 1-(Triisopropylsilyl)­oct-1-yn-3-one (14) Triisopropylsilyl acetylene (TIPS-acetylene, 9.12 mL, 40.7 mmol, 1.2 equiv) was dissolved in anhydrous THF and cooled to 4 °C, followed by the addition of n-BuLi (2.5 M in hexane, 16.3 mL, 40.7 mmol, 1.2 equiv) under an argon atmosphere. The reaction mixture was stirred for 15 min, after which neat Weinreb amide 13 (5.4 g, 33.9 mmol, 1.0 equiv) was added. After 30 min, the reaction was quenched by the addition of saturated aqueous NH4Cl. The aqueous layer was extracted with EtOAc, and the combined organic layers were dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (99:1) to afford pure product 14 as a colorless oil (8.66 g, 91%). R f = 0.2 (Hex/EtOAc (99:1), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 2.55 (t, J = 7.4 Hz, 2H), 1.73–1.67 (m, 2H), 1.34–1.29 (m, 4H), 1.16–1.06 (m, 21H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 188.3, 104.4, 95.5, 45.8, 31.3, 24.1, 22.5, 18.6, 14.0, 11.1; HRMS (ESI) m/z: [M + H]+ calculated for C17H33OSi+, 281.2295; found, 281.2278. (S)-1-(Triisopropylsilyl)­oct-1-yn-3-ol (15a) To a solution of RuCl­[(S,S)-TsDPEN]­(mesitylene) (150 mg, 0.241 mmol) in DCM (5 mL) was added KOH (92 mg, 1.64 mmol, 6.8 equiv), and the reaction mixture was stirred at room temperature for 45 min. The mixture was washed with several times with H2O, and the DCM solution was transferred to another flask. The organic solution was dried over CaH2, and the supernatant was concentrated under reduced pressure to afford a purple solid. The residue was diluted with i-PrOH (4 mL), and a solution of ketone 14 (4.50 g, 16.0 mmol) in i-PrOH (4 mL) was added. After stirring at room temperature for 3 h, the reaction mixture was concentrated to afford a residue, which was purified by chromatography on silica gel Hex/EtOAc (98:2) to afford alcohol 15a as a colorless oil (4.1 g, 90%, ee ≥ 99.5%; determined by chiral HPLC of the corresponding derivative 27a; see the Supporting Information). R f = 0.2 (Hex/EtOAc (98:2), KMnO4 stain). The enantiomeric ratio was determined after TIPS deprotection and alcohol protection using chiral HPLC [250 mm × 4.6 mm, 5 μm, Daicel Chiralpak IG, isocratic Hex/MTBE (2:8) containing 0.05% glacial acetic acid, 1.0 mL/min, 220 nm, t R = 6.81 min (99.9%, (S,S)-isomer)]. 1H NMR (600 MHz, CDCl3) δ 4.38 (q, J = 6.3 Hz, 1H), 1.75–1.65 (m, 3H), 1.51–1.45 (m, 2H), 1.34–1.29 (m, 4H), 1.11–1.02 (m, 21H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 109.1, 85.6, 63.2, 38.1, 31.6, 25.0, 22.7, 18.7, 14.1, 11.3. (R)-1-(Triisopropylsilyl)­oct-1-yn-3-ol (15b) Colorless oil (3.64 g, 90%, 99% ee; determined by chiral HPLC of the corresponding derivative 27b; see the Supporting Information). The enantiomeric ratio was determined after TIPS deprotection and alcohol protection using chiral HPLC [250 mm × 4.6 mm, 5 μm, Daicel Chiralpak IG, isocratic Hex/MTBE (2:8) containing 0.05% glacial acetic acid, 1.0 mL/min, 220 nm, t R = 6.82 min (0.5%, (S,S)-isomer)], 7.48 min [99.5%, (R,R)-isomer]. R f = 0.2 (Hex/EtOAc (98:2), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 4.39 (q, J = 6.3 Hz, 1H), 1.76–1.65 (m, 3H), 1.51–1.45 (m, 2H), 1.34–1.29 (m, 4H), 1.11–1.02 (m, 21H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 109.1, 85.6, 63.2, 38.1, 31.6, 25.0, 22.7, 18.7, 14.1, 11.3. (S)-Oct-1-yn-3-ol (16a) To a solution of alcohol 15a (2.5 g, 8.85 mmol, 1.0 equiv) in THF (10 mL) was added TBAF (1.0 M in THF, 10.6 mL, 10.6 mmol, 1.2 equiv) at room temperature. After stirring for 3 h, the reaction was quenched by the addition of saturated aqueous NH4Cl. The aqueous layer was extracted with EtOAc, and the combined organic layers were washed with brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (95:5) to give pure product 16a as a colorless oil (1.0 g, 90%). R f = 0.25 (Hex/EtOAc (9:1), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 4.37 (t, J = 5.9 Hz, 1H), 2.46 (d, J = 2.1 Hz, 1H), 1.90–1.87 (brs, 1H), 1.75–1.66 (m, 2H), 1.49–1.42 (m, 2H), 1.35–1.28 (m, 4H), 0.89 (t, J = 6.9 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 85.2, 73.0, 62.5, 37.8, 31.6, 24.8, 22.7, 14.1. (R)-Oct-1-yn-3-ol (16b) Colorless oil (1.0 g, 90%). R f = 0.25 (Hex/EtOAc (9:1), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 4.37 (td, J = 5.9, 2.1 Hz, 1H), 2.46 (d, J = 2.1 Hz, 1H), 1.90–1.86 (brs, 1H), 1.75–1.65 (m, 2H), 1.49–1.42 (m, 2H), 1.35–1.27 (m, 6H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 85.2, 73.0, 62.5, 37.8, 31.6, 24.8, 22.7, 14.1. 10-(Trimethylsilyl)­dec-9-ynoic Acid (17) To the solution of trimethylsilylacetylene (8.0 mL, 56.0 mmol, 2.5 equiv) in dry THF (50 mL) was added dropwise n-BuLi (2.5 M in hexane, 23.3 mL, 58.2 mmol, 2.6 equiv) at −78 °C. After stirring for 15 min, 1,3-dimethyl-3,4,5,6-tetrahydro-2­(1H)-pyrimidinone (DMPU, 40 mL) was added, and the reaction mixture was stirred for an additional 1 h at −78 °C. A solution of 8-bromooctanoic acid (5.0 g, 22.4 mmol, 1.0 equiv) in DMPU (10 mL) was added dropwise. The reaction was allowed to slowly warm to room temperature and stirred overnight. The reaction was quenched by the addition of saturated aqueous NH4Cl and 1.0 M HCl (to pH 2–3) and extracted with EtOAc (2 × 100 mL). The combined organic layers were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (9:1) to give pure product 17 as a colorless oil (5.02 g, 93%). R f = 0.2 (Hex/EtOAc (95:5), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 2.35 (t, J = 7.5 Hz, 2H), 2.21 (t, J = 7.2 Hz, 2H), 1.66–1.60 (m, 2H), 1.54–1.47 (m, 2H), 1.42–1.29 (m, 6H), 0.14 (s, 9H); 13C NMR (151 MHz, CDCl3) δ 180.2, 107.7, 84.5, 34.2, 29.0, 28.8, 28.7, 28.7, 24.7, 20.0, 0.32; HRMS (ESI) m/z: [M – H]− calculated for C13H23O2Si–, 239.1473; found, 239.1482. Methyl Dec-9-ynoate (18) To the solution of compound 17 (10.38 g, 43.2 mmol, 1.0 equiv) in MeOH (100 mL) was added dropwise conc. H2SO4 (3 drops) at reflux. After stirring for 3 h, the reaction mixture was cooled to room temperature and concentrated under reduced pressure. The resulting residue was dissolved in THF, and TBAF (1.0 M in THF, 36.7 mL, 36.7 mmol, 0.85 equiv) was added. The reaction mixture was stirred at room temperature for 30 min and then diluted with EtOAc and saturated aqueous NH4Cl. The organic layer was washed with water, brine, dried over MgSO4, filtered, and concentrated. The residue was purified by column chromatography on silica gel using Hex/EtOAc (95:5) to give pure product 18 as a colorless oil (7.51 g, 95%). R f = 0.25 (Hex/EtOAc (95:5), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 3.66 (s, 3H), 2.30 (t, J = 7.5 Hz, 2H), 2.17 (td, J = 7.1, 2.6 Hz, 2H), 1.93 (t, J = 2.6 Hz, 1H), 1.65–1.59 (m, 2H), 1.54–1.49 (m, 2H), 1.33–1.30 (m, 6H); 13C NMR (151 MHz, CDCl3) δ 174.4, 84.8, 68.3, 51.6, 34.2, 29.1, 28.8, 28.6, 28.5, 25.0, 18.5. 2-(Non-8-yn-1-yl)-1,3-dioxolane (19) To a solution of ester 18 (4.0 g, 21.9 mmol, 1.0 equiv) in dry toluene (60 mL) was dropwise added DIBAL-H (1.0 M in heptane, 23.0 mL, 23.0 mmol, 1.05 equiv) at −78 °C. After stirring for 30 min, the reaction mixture was quenched by addition to saturated aqueous Rochelle salt and stirred at room temperature for 10 min. The mixture was diluted with EtOAc and water. The organic layer was washed with water and brine, dried over MgSO4, filtered, and concentrated under reduced pressure to afford a crude aldehyde (3.40 g, quant.), which was used in the next step without further purification. To a solution of the above aldehyde in toluene (50 mL) was added ethylene glycol (1.35 mL, 24.1 mmol, 1.1 equiv) and p-toluenesulfonic acid monohydrate (833 mg, 4.38 mmol, 0.2 equiv). The reaction mixture was refluxed for 2 h using a Dean–Stark trap. After cooling to room temperature, the reaction mixture was diluted with EtOAc and H2O. The organic layer was washed with water, brine, dried over MgSO4, filtered, and concentrated. The residue was purified by column chromatography on silica gel using Hex/EtOAc (95:5) to give pure product 19 as a light yellow liquid (2.72 g, 63%). R f = 0.25 (Hex/EtOAc (95:5), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 4.83 (t, J = 4.8 Hz, 1H), 3.98–3.93 (m, 2H), 3.87–3.80 (m, 2H), 2.17 (td, J = 7.1, 2.6 Hz, 2H), 1.93 (t, J = 2.6 Hz, 1H), 1.67–1.62 (m, 2H), 1.54–1.48 (m, 2H), 1.54–1.48 (m, 4H), 1.44–1.37 (m, 4H); 13C NMR (151 MHz, CDCl3) δ 104.8, 84.9, 68.2, 65.0, 34.0, 29.5, 29.1, 28.8, 28.6, 24.2, 18.5; HRMS (ESI) m/z: [M + H]+ calculated for C12H21O2 +, 197.1536; found, 197.1525. (E)-2-(9-Iodonon-8-en-1-yl)-1,3-dioxolane (20) To a solution of alkyne 19 (1.0 g, 5.10 mmol) in THF (20 mL) was added Cp2ZrCl2 (2.52 g, 8.67 mmol, 1.7 equiv) and LiHBEt3 (1.0 M in THF, 6.63 mL, 6.63 mmol, 1.3 equiv) at 4 °C. The reaction mixture was stirred at room temperature for 10 min, after which iodine (1.52 g, 6.12 mmol, 1.2 equiv) was added, and the mixture was stirred for an additional 10 min. The reaction was quenched by dilution with EtOAc (200 mL) and saturated aqueous NH4Cl (80 mL). The organic layer was washed with saturated aqueous Na2S2O3, brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (95:5) to give pure product 20 as a colorless liquid (970 mg, 59%). R f = 0.25­(Hex/EtOAc (95:5), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 6.50 (dt, J = 14.3, 7.2 Hz, 1H), 5.96 (dt, J = 14.3, 1.4 Hz, 1H), 4.83 (t, J = 4.8 Hz, 1H), 3.98–3.92 (m, 2H), 3.87–3.81 (m, 2H), 2.03 (qd, J = 7.2, 1.4 Hz, 2H), 1.66–1.62 (m, 2H), 1.42–1.26 (m, 12H); 13C NMR (151 MHz, CDCl3) δ 146.9, 104.8, 74.4, 65.0, 36.1, 34.0, 29.5, 29.4, 28.9, 28.4, 24.2. (S,E)-17-(1,3-Dioxolan-2-yl)­heptadec-9-en-7-yn-6-ol (21a) To a solution of chiral alkyne 16a (200 mg, 1.58 mmol) in Et3N (2 mL) were added Pd­(PPh3)4 (90 mg, 0.079 mmol, 0.05 equiv) and CuI (90 mg, 0.47 mmol, 0.3 equiv). The mixture was stirred at room temperature for 5 min, followed by addition of a solution of vinyl iodide 20 (514 mg, 1.58 mmol, 1.0 equiv) in Et3N (2 mL). The reaction mixture was stirred for 30 min and then diluted with EtOAc (30 mL) and saturated aqueous NH4Cl (20 mL). The organic layer was washed with water and brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (95:5) to afford pure product 21a as a light yellow liquid (218 mg, 43%). R f = 0.25 (Hex/EtOAc (9:1), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 6.12 (dt, J = 15.7, 7.1 Hz, 1H), 5.47 (dd, J = 15.7, 1.5 Hz, 1H), 4.83 (t, J = 4.8 Hz, 1H), 4.45 (q, J = 5.4 Hz, 1H), 3.99–3.92 (m, 2H), 3.87–3.81 (m, 2H), 2.08 (qd, J = 7.1, 1.5 Hz, 2H), 1.86 (d, J = 5.2 Hz, 1H), 1.73–1.67 (m, 2H), 1.66–1.61 (m, 2H), 1.47–1.26 (m, 14H), 0.89 (t, J = 6.9 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 145.5, 109.0, 104.8, 88.8, 83.7, 65.0, 63.1, 38.1, 34.0, 33.2, 31.6, 29.6, 29.4, 29.1, 28.7, 25.0, 24.2, 22.7, 14.1; HRMS (ESI) m/z: [M + Na]+ calculated for C20H34O3Na+, 345.2400; found, 345.2398. (R,E)-17-(1,3-Dioxolan-2-yl)­heptadec-9-en-7-yn-6-ol (21b) Light yellow liquid (408 mg, 52%). R f = 0.25 (Hex/EtOAc (9:1), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 6.12 (dt, J = 15.8, 7.1 Hz, 1H), 5.47 (dq, J = 15.8, 1.6 Hz, 1H), 4.83 (t, J = 4.8 Hz, 1H), 4.45 (q, J = 5.3 Hz, 1H), 3.99–3.92 (m, 2H), 3.87–3.81 (m, 2H), 2.08 (qd, J = 7.1, 1.6 Hz, 1H), 1.85 (d, J = 5.2 Hz, 1H), 1.73–1.67 (m, 2H), 1.66–1.61 (m, 2H), 1.47–1.26 (m, 14H), 0.89 (t, J = 6.9 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 145.5, 109.0, 104.8, 88.8, 83.7, 65.0, 63.1, 38.1, 34.0, 33.2, 31.6, 29.6, 29.4, 29.1, 28.7, 25.0, 24.2, 22.7, 14.1; HRMS (ESI) m/z: [M + Na]+ calculated for C20H34O3Na+, 345.2400; found, 345.2409. (S,E)-17-(1,3-Dioxolan-2-yl)­heptadec-9-en-7-yn-6-yl 4-Methoxybenzoate (22a) To a solution of DMAP (10 mg, 0.086 mmol, 0.11 equiv) in DCM (4 mL) was added 4-methoxy benzoyl chloride (198 mg, 1.16 mmol, 1.5 equiv) at 4 °C. The mixture was stirred for 10 min, followed by the addition of a solution of alcohol 21a (250 mg, 0.78 mmol) in DCM (4 mL) and Et3N (432 μL, 3.1 mmol, 4.0 equiv) at room temperature. The reaction mixture was stirred for 30 min and then diluted with DCM (30 mL) and saturated aqueous NH4Cl (20 mL). The organic layer was washed with water and brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (95:5) to give pure ester 22a as a light brown liquid (314 mg, 89%); R f = 0.2 (Hex/EtOAc (95:5), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 8.02 (d, J = 8.9 Hz, 2H), 6.91 (d, J = 8.9 Hz, 2H), 6.16 (dt, J = 15.8, 6.9 Hz, 1H), 5.69 (td, J = 6.5, 1.6 Hz, 1H), 5.48 (dd, J = 15.8, 1.6 Hz, 1H), 4.83 (t, J = 4.8 Hz, 1H), 3.98–3.92 (m, 2H), 3.86 (s, 3H), 3.86–3.81 (m, 2H), 2.10–2.05 (m, 2H), 1.93–1.83 (m, 1H), 1.66–1.61 (m, 2H), 1.54–1.48 (m, 2H), 1.42–1.24 (m, 14H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 165.5, 163.6, 146.1, 132.0, 122.7, 113.7, 108.9, 104.8, 85.4, 84.2, 65.1, 65.0, 55.6, 35.2, 34.0, 33.2, 31.5, 29.6, 29.4, 29.1, 28.7, 24.9, 24.2, 22.6, 14.1; HRMS (ESI) m/z: [M + Na]+ calculated for C28H40O5Na+, 479.2768; found, 479.2756. (S,E)-17-(1,3-Dioxolan-2-yl)­heptadec-9-en-7-yn-6-yl 4-Methoxybenzoate (22b) Light brown oil (506 mg, 89%). R f = 0.20 (Hex/EtOAc (95:5), KMnO4 stain); 1H NMR (600 MHz, CDCl3) δ 8.02 (d, J = 8.9 Hz, 2H), 6.91 (d, J = 8.9 Hz, 2H), 6.16 (dt, J = 15.8, 7.1 Hz, 1H), 5.69 (td, J = 6.5, 1.5 Hz, 1H), 5.47 (dq, J = 15.8, 1.5 Hz, 1H), 4.83 (t, J = 4.8 Hz, 1H), 3.98–3.92 (m, 2H), 3.86 (s, 3H), 3.85–3.81 (m, 2H), 2.08 (qd, J = 7.4, 1.3 Hz, 2H), 1.92–1.84 (m, 1H), 1.65–1.62 (m, 2H), 1.53–1.49 (m, 2H), 1.42–1.25 (m, 14H), 0.89 (t, J = 7.1 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 165.5, 163.6, 146.1, 132.0, 122.7, 113.7, 108.9, 104.8, 85.4, 84.2, 65.1, 65.0, 55.6, 35.2, 34.0, 33.2, 31.5, 29.6, 29.4, 29.1, 28.7, 25.0, 24.2, 22.6, 14.1; HRMS (ESI)­m/z: [M + Na]+ calculated for C28H40O5Na+, 479.2768; found, 479.2750. 6­(S),9­(S),10­(S)-17-(1,3-Dioxolan-2-yl)-9,10-dihydroxyheptadec-7-yn-6-yl 4-Methoxybenzoate (23a) To a mixture of K3[Fe­(CN)6] (648 mg, 1.97 mmol, 3.0 equiv), K2CO3 (90.7 mg, 1.97 mmol, 3.0 equiv), and (DHQ)2PHAL (5.04 mg, 6.57 μmol, 1.0 mol %) in tert-BuOH/H2O (1:1, 10 mL) cooled to 4 °C was added K2OsO4·2H2O (2.4 mg, 6.57 μmol, 1.0 mol %) followed by methanesulfonamide (62.4 mg, 0.657 mmol, 1.0 equiv). After the mixture was stirred for 5 min at 4 °C, compound 22a (300 mg, 0.657 mmol) was added in one portion. The reaction mixture was stirred at 4 °C for 24 h and then quenched with solid Na2SO3 (124 mg, 0.986 mmol, 1.5 equiv). The mixture was stirred for an additional 45 min, and the solid was removed by vacuum filtration. The filtrate was extracted with EtOAc (3 × 50 mL), and the combined organic layers were washed with brine, dried over MgSO4, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (7:3) to give crude product 23a as a white solid (367 mg, 80%, ee ≥ 99.5%; see the Supporting Information). The enantiomeric ratio was determined by chiral HPLC [250 mm × 4.6 mm, 5 μm, Daicel Chiralpak IG, 98:2 to 96:4 hexane/methyl tert-butyl ether (MTBE) containing 0.05% glacial acetic acid, 1.0 mL/min, 220 nm, t R = 5.96 min (99.9%, (S,S)-isomer)]. R f = 0.1 (Hex/EtOAc (7:3), KMnO4 stain); 1H NMR (600 MHz, CDCl3) δ 7.98 (d, J = 8.9 Hz, 2H), 6.91 (d, J = 8.9 Hz, 2H), 5.55 (td, J = 6.6, 1.1 Hz, 1H), 4.82 (t, J = 4.8 Hz, 1H), 4.17– 1.45 (m, 1H), 3.96–3.92 (m, 2H), 3.85 (s, 3H), 3.94–3.80 (m, 2H), 3.62–3.57 (m, 1H), 2.85–2.75 (brs, 1H), 2.70–2.60 (brs, 1H), 1.92–1.82 (m, 2H), 1.64–1.60 (m, 2H), 1.52–1.43 (m, 4H), 1.41–1.35 (m, 2H), 1.50–1.44 (m, 12H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 165.5, 163.7, 132.0, 122.4, 113.8, 104.8, 84.3, 84.0, 74.9, 66.3, 64.9, 64.4, 55.6, 34.8, 34.0, 32.5, 31.4, 29.6, 29.56, 29.55, 25.6, 24.9, 24.2, 22.6, 14.1; HRMS (ESI) m/z: [M + Na]+ calculated for C28H42O7Na+ 513.2823; found 513.2775. 6­(R),9­(R),10­(R)-17-(1,3-Dioxolan-2-yl)-9,10-dihydroxyheptadec-7-yn-6-yl 4-Methoxybenzoate (23b) White solid (202 mg, 75%, ee ≥ 99.5%; see the Supporting Information). R f = 0.1 (Hex/EtOAc (7:3), KMnO4 stain). The enantiomeric ratio was determined by chiral HPLC [250 mm × 4.6 mm, 5 μm, Daicel Chiralpak IG, 98:2 to 96:4 hexane/methyl tert-butyl ether (MTBE) containing 0.05% glacial acetic acid, 1.0 mL/min, 220 nm, t R = 7.75 min (99.9%, (R,R)-isomer)]. R f = 0.25 (Hex/EtOAc (7:3), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 8.00 (d, J = 8.9 Hz, 2H), 6.92 (d, J = 8.9 Hz, 2H), 5.57 (td, J = 6.6, 1.3 Hz, 1H), 4.83 (t, J = 4.8 Hz, 1H), 4.18 (t, J = 5.5 Hz, 1H), 3.97–3.93 (m, 2H), 3.86 (s, 3H), 3.85–3.81 (m, 2H), 3.61 (d, J = 1.9 Hz, 1H), 2.49 (d, J = 6.2 Hz, 1H), 2.47–2.44 (m, 1H), 1.93–1.83 (m, 2H), 1.66–1.60 (m, 2H), 1.52–1.45 (m, 4H), 1.41–1.36 (m, 2H), 1.36–1.26 (m, 12H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (151 MHz, CDCl3) δ 165.5, 163.7, 132.0, 122.4, 113.8, 104.8, 84.4, 84.0, 74.9, 66.3, 65.0, 64.4, 55.6, 34.8, 34.0, 32.5, 31.4, 29.6, 29.57, 29.56, 25.6, 24.9, 24.2, 22.6, 14.1; HRMS (ESI) m/z: [M + Na]+ calculated for C28H42O7Na+ 513.2823; found 513.2773. 6­(S),9­(S),10­(S,E)-17-(1,3-Dioxolan-2-yl)­heptadec-7-ene-6,9,10-triol (24a) Compound 23a (250 mg, 0.50 mmol) was dissolved in a mixture of MeOH (1.0 mL), THF (1.0 mL), and water (0.5 mL), and LiOH (61 mg, 2.5 mmol, 5.0 equiv) was added at 4 °C. The reaction mixture was stirred at room temperature for 1 h and then quenched by the addition of saturated aqueous NH4Cl. The mixture was diluted with EtOAc, and the aqueous layer was extracted with EtOAc (2 × 50 mL). The combined organic layers were dried over MgSO4, filtered, and concentrated under reduced pressure to afford the corresponding alcohol, which was used in the next step without further purification. To a solution of the above alcohol in THF (5 mL) was added Red-Al (65% in toluene, 1.8 mL, 7.5 mmol) at 4 °C. The reaction mixture was stirred at 60 °C for 15 min and then quenched by the addition of EtOAc and saturated aqueous Rochelle salt. The aqueous layer was extracted with EtOAc (2 × 50 mL). The combined organic layers were dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (2:8) to give crude product 24a as a white solid (108 mg, 60%). R f = 0.25 (Hex/EtOAc (4:6), KMnO4 stain). 1H NMR (600 MHz, MeOD) δ 5.70 (qd, J = 15.6, 5.8 Hz, 2H), 4.80 (t, J = 4.8 Hz, 1H), 4.05 (q, J = 6.2 Hz, 1H), 3.95–3.88 (m, 3H), 3.85–3.78 (m, 2H), 3.43–3.39 (m, 1H), 1.63–1.58 (m, 2H), 1.56–1.45 (m, 4H), 1.43–1.38 (m, 2H), 1.37–1.29 (m, 12H), 0.91 (t, J = 7.0 Hz, 3H); 13C NMR (151 MHz, MeOD) δ 136.6, 131.0, 105.7, 76.5, 75.8, 73.1, 65.8, 38.4, 35.0, 33.6, 33.0, 30.7, 30.6, 30.6, 26.9, 26.2, 25.1, 23.7, 14.4; HRMS (ESI) m/z: [M + Na]+ calculated for C20H38O5Na+, 381.2611; found, 381.2612. 6­(R),9­(R),10­(R,E)-17-(1,3-Dioxolan-2-yl)­heptadec-7-ene-6,9,10-triol (24b) White solid (48.5 mg, 68%). R f = 0.25 (Hex/EtOAc (4:6), KMnO4 stain). 1H NMR (600 MHz, MeOD) δ 5.70 (qd, J = 15.6, 5.8 Hz, 2H), 4.80 (t, J = 4.8 Hz, 1H), 4.05 (q, J = 6.2 Hz, 1H), 3.95–3.89 (m, 3H), 3.84–3.78 (m, 2H), 3.43–3.39 (m, 1H), 1.63–1.58 (m, 2H), 1.56–1.45 (m, 4H), 1.43–1.38 (m, 2H), 1.37–1.29 (m, 12H), 0.91 (t, J = 7.0 Hz, 3H); 13C NMR (151 MHz, MeOD) δ 136.6, 131.0, 105.7, 76.5, 75.8, 73.0, 65.8, 38.4, 34.9, 33.6, 33.0, 30.7, 30.6, 30.6, 26.9, 26.2, 25.1, 23.7, 14.4; HRMS (ESI) m/z: [M + Na]+ calculated for C20H38O5Na+, 381.2611; found, 381.2609. 5­(S),8­(S),9­(S,E)-9-(7-(1,3-Dioxolan-2-yl)­heptyl)-3,3,11,11-tetraethyl-5-pentyl-8-((triethylsilyl)­oxy)-4,10-dioxa-3,11-disilatridec-6-ene (25a) To a solution of 24a (130 mg, 0.36 mmol) in DMF (2 mL) were added imidazole (172 mg, 2.52 mmol, 7.0 equiv) and chlorotriethylsilane (301 μL, 1.80 mmol, 5.0 equiv) at 4 °C. The reaction mixture was stirred at room temperature for 4 h and then diluted with EtOAc and saturated aqueous NH4Cl. The organic layer was washed with brine (2 × 50 mL), dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (97:3) to give crude product 25a as a colorless oil (220 mg, 87%). R f = 0.2 (Hex/EtOAc (98:2), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 5.66 (qd, J = 15.6, 4.1 Hz, 2H), 4.84 (t, J = 4.8 Hz, 1H), 4.14–4.09 (m, 2H), 3.99–3.93 (m, 2H), 3.87–3.81 (m, 2H), 3.57–3.53 (m, 1H), 1.66–1.62 (m, 2H), 1.52–1.48 (m, 4H), 1.43–1.38 (m, 2H), 1.32–1.24 (m, 14H), 0.98–0.93 (m, 27H), 0.87 (t, J = 7.0 Hz, 3H), 0.62–0.55 (m, 18H); 13C NMR (151 MHz, CDCl3) δ 134.0, 128.6, 104.9, 75.9, 75.0, 73.4, 65.0, 38.7, 34.1, 32.1, 31.4, 29.9, 29.72, 29.70, 26.3, 25.2, 24.3, 22.8, 14.2, 7.09, 7.06, 7.03, 5.28, 5.12, 5.08. 5­(R),8­(R),9­(R,E)-9-(7-(1,3-Dioxolan-2-yl)­heptyl)-3,3,11,11-tetraethyl-5-pentyl-8-((triethylsilyl)­oxy)-4,10-dioxa-3,11-disilatridec-6-ene (25b) Colorless oil (240 mg, 95%). R f = 0.2 (Hex/EtOAc (98:2), KMnO4 stain); 1H NMR (600 MHz, CDCl3) δ 5.66 (qd, J = 15.6, 4.1 Hz, 2H), 4.84 (t, J = 4.8 Hz, 1H), 4.14–4.09 (m, 2H), 3.99–3.92 (m, 2H), 3.87–3.81 (m, 2H), 3.57–3.53 (m, 1H), 1.66–1.62 (m, 2H), 1.52–1.47 (m, 2H), 1.44–1.37 (m, 4H), 1.34–1.20 (m, 14H), 0.98–0.93 (m, 27H), 0.87 (t, J = 7.0 Hz, 3H), 0.62–0.55 (m, 18H); 13C NMR (151 MHz, CDCl3) δ 134.0, 128.6, 104.9, 75.9, 75.0, 73.4, 65.0, 38.7, 34.1, 32.1, 31.4, 29.9, 29.72, 29.70, 26.3, 25.2, 24.3, 22.8, 14.2, 7.09, 7.07, 7.04, 5.3, 5.12, 5.08. 9­(S),10­(S),13­(S,E)-9,10,13-Tris­((triethylsilyl)­oxy)­octadec-11-enal To a solution of silyl compound 25a (200 mg, 0.285 mmol) in DCM (5 mL) were added 2,6-lutidine (726 μL, 6.27 mmol, 22.0 equiv) and trimethylsilyl trifluoromethanesulfonate (TMSOTf, 774 μL, 4.28 mmol, 15 equiv) at −20 °C. The reaction mixture was stirred at −20 °C for 1 h, followed by the addition of H2O (2.0 mL). The mixture was stirred at room temperature for 1 h and diluted with DCM (15 mL) and 1.0 M aqueous HCl (1.5 mL). The organic layer was washed with H2O and brine, dried over MgSO4, filtered, and concentrated under reduced pressure to afford crude aldehyde as a colorless oil (161.4 mg, 86% crude yield). R f = 0.3 (Hex/EtOAc (95:5), KMnO4 stain). The resulting aldehyde was used without further purification. 9­(S),10­(S),13­(S,E)-9,10,13-Tris­((triethylsilyl)­oxy)­octadec-11-enoic Acid (25c) A mixture of NaH2PO4·2H2O (290 mg, 1.86 mmol, 8.0 equiv) and NaClO2 (78%, 232 mg, 2.00 mmol, 8.6 equiv) in H2O (0.5 mL) was added to a solution of crude aldehyde (153 mg, 0.23 mmol) in tert-BuOH (0.5 mL) and 2-methyl-2-butene (0.5 mL) at 4 °C. The reaction mixture was stirred at room temperature for 1 h and then diluted with EtOAc and water. The organic layer was washed with H2O and brine, dried over MgSO4, filtered, and concentrated under reduced pressure to afford crude acid 25c as a colorless oil (150 mg, 97% crude yield). R f = 0.2 (Hex/EtOAc (9:1), KMnO4 stain). The product was used without further purification. 1H NMR (600 MHz, CDCl3) δ 5.71–5.61 (m, 2H), 4.16–4.09 (m, 2H), 3.58–3.52 (m, 1H), 2.34 (t, J = 7.6 Hz, 2H), 1.65–1.59 (m, 2H), 1.54–1.48 (m, 2H), 1.47–1.37 (m, 2H), 1.34–1.22 (m, 14H), 0.98–0.93 (m, 27H), 0.87 (t, J = 7.0 Hz, 3H), 0.62–0.55 (m, 18H); HRMS (ESI) m/z: [M – C6H15Si]− calculated for C30H61O5Si2 –, 557.4063; found, 557.4087. 9­(R),10­(R),13­(R,E)-9,10,13-Tris­((triethylsilyl)­oxy)­octadec-11-enoic Acid (25d) Colorless oil (149 mg, 83% crude yield over 2 steps). R f = 0.2 (Hex/EtOAc (9:1), KMnO4 stain). 1H NMR (600 MHz, CDCl3) δ 5.71–5.61 (m, 2H), 4.14–4.10 (m, 2H), 3.56–3.53 (m, 1H), 2.28 (t, J = 7.6 Hz, 2H), 1.65–1.59 (m, 2H), 1.54–1.48 (m, 2H), 1.47–1.37 (m, 2H), 1.34–1.22 (m, 14H), 0.98–0.93 (m, 27H), 0.87 (t, J = 7.0 Hz, 3H), 0.62–0.55 (m, 18H); HRMS (ESI) m/z: [M – C6H15Si]− calculated for C30H61O5Si2 –, 557.4063; found, 557.4084. 9­(S),10­(S),13­(S,E)-9,10,13-Trihydroxyoctadec-11-enoic Acid (26a) TBAF (1.0 M in THF, 400 μL, 3.0 equiv) was added to a solution of the above crude acid 25c (90 mg, 0.13 mmol) in THF (2.0 mL) at room temperature. The reaction mixture was stirred for 3 h and diluted with EtOAc (15 mL) and saturated aqueous NH4Cl (10 mL). The organic layer was washed with water and brine, dried over MgSO4, filtered, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel using Hex/EtOAc (3:7) containing 0.5% glacial acetic acid to give pure product 26a as a white solid (27.5 mg, 63%, ee ≥ 99.5%; determined by chiral HPLC of the corresponding ester derivative 29a; see the Supporting Information). R f = 0.25 (Hex/EtOAc (3:7) with 0.5% AcOH, KMnO4 stain). The enantiomeric ratio was determined after ester protection and TES deprotection using chiral HPLC [250 mm × 4.6 mm, 5 μm, Daicel Chiralpak IG, 98:2 to 92:8 hexane/methyl tert-butyl ether (MTBE) containing 0.05% glacial acetic acid, 1.0 mL/min, 220 nm, t R = 8.34 min (99.9%, (S,S)-isomer)]. 1H NMR (600 MHz, MeOD) δ 5.70 (qd, J = 15.6, 5.8 Hz, 2H), 4.05 (q, J = 6.2 Hz, 1H), 3.90 (t, J = 5.8 Hz, 1H), 3.43–3.39 (m, 1H), 2.28 (t, J = 7.4 Hz, 2H), 1.63–1.57 (m, 2H), 1.55–1.48 (m, 2H), 1.37–1.29 (m, 14H), 0.91 (t, J = 6.8 Hz, 3H); 13C NMR (151 MHz, MeOD) δ 177.7, 136.6, 131.0, 76.5, 75.8, 73.1, 38.4, 34.9, 33.5, 33.0, 30.7, 30.4, 30.2, 26.8, 26.2, 26.1, 23.7, 14.4; HRMS (ESI) m/z: [M – H]− calculated for C18H33O5 –, 329.2333; found, 329.2343. [α] D 21 −11.5 (c 0.5, MeOH). 9­(R),10­(R),13­(R,E)-9,10,13-Trihydroxyoctadec-11-enoic Acid (26b) White solid (22.2 mg, 48%, ee ≥ 99.5%; ee determined by chiral HPLC of the corresponding ester derivative 29b; determined by chiral HPLC of the corresponding ester derivative 29b; see the Supporting Information). R f = 0.25 (Hex/EtOAc (3:7) with 0.5% AcOH, KMnO4 stain). The enantiomeric ratio was determined after ester protection and TES deprotection by chiral HPLC [250 mm × 4.6 mm, 5 μm, Daicel Chiralpak IG, 98:2 to 92:8 hexane/methyl tert-butyl ether (MTBE) containing 0.05% glacial acetic acid, 1.0 mL/min, 220 nm, t R = 10.07 min (99.9%, (R,R)-isomer)]. 1H NMR (600 MHz, MeOD) δ 5.70 (qd, J = 15.6, 5.8 Hz, 2H), 4.05 (q, J = 6.1 Hz, 1H), 3.90 (t, J = 5.8 Hz, 1H), 3.43–3.39 (m, 1H), 2.28 (t, J = 7.4 Hz, 2H), 1.63–1.57 (m, 2H), 1.55–1.48 (m, 2H), 1.37–1.29 (m, 14H), 0.91 (t, J = 6.8 Hz, 3H); 13C NMR (151 MHz, MeOD) δ 177.7, 136.6, 131.00, 76.50, 75.8, 73.1, 38.3, 34.9, 33.5, 33.0, 30.7, 30.4, 30.2, 26.8, 26.2, 26.1, 23.7, 14.4; HRMS (ESI) m/z: [M – H]− calculated for C18H33O5 –, 329.2333; found, 329.2347. [α] D 21 + 11.6 (c 0.5, MeOH). Supplementary Material